Grants per year
Search results
-
Finished
Prot. 20-HMedIdeS-17: An open-label, controlled, randomized Phase 3 trial evaluating 12-month kidney function in highly sensitized (cPRA =99.9%) kidney transplant patients with positive crossmatch against a deceased donor, comparing desensitization using
Christopher, D. A. (PD/PI)
CTI Clinical Trial and Consulting Services, Hansa Biopharma AB
1/26/22 → 1/26/25
Project: Research project